:: January 2012

Welcome to our Monthly Online Newsletter!

Our Highlighted Articles are now being included in our Weekly Featured Articles site. If you have not already signed up for our Alerts newsletter which links to this site, please do so at our sign up page. Stay current and save time. Free access to our Weekly Featured Articles and Weekly Featured Brain Articles.

NCG - American Association of Clinical Endocrinologists medical guidelines for the clinical use of dietary supplements and nutraceuticals. (2003)

NGC - Iron ingestion: an evidence-based consensus guideline for out-of-hospital management. (2005)

Featured site

NIH - Dietary Supplements: Background Information

Guide to Herbs & Supplements

NCCAM - Herbs at a Glance

NCI FACT SHEET: Antioxidants and Cancer Prevention

NIH - Annual Bibliographies of Significant Advances in Dietary Supplement Research

NIH - Antioxidants

NIH - Dietary Supplements

NIH - Garlic

NIH - Green Tea

NIH - Medical Encyclopedia Safety and vitamins

NIH - Medical Encyclopedia Vitamins

NIH - NCCAM What's in the Bottle? An Introduction to Dietary Supplements

NIH - Office of Dietary Supplements

NIH - Vitamin and Mineral Supplement Fact Sheets

NIH - Vitamins and Minerals

Cardiovascular: General

Cancer: Prostate

Depression

Vitamins

Cardiovascular: General

The role of omega-3 fatty acids in cardiac protection: an overview. ( Front Biosci. 2005) "Fish oil has historically been thought to be good for cardiovascular health; however, data have revealed a stronger cardioprotective role of fish oil in recent years. Fish oil and specifically omega-3 fatty acids exhibit cardioprotective effects by mainly improving mortality in coronary artery disease patients. This is achieved through multiple mechanisms with the antiarrhythmic mechanism being the most prominent one. Effects on sodium and calcium channels and heart rate variability are well-accepted mechanisms of how omega-3 fatty acids exercise antiarrhythmic effects."

Cancer: Prostate

Chemoprevention of prostate cancer. (Crit Rev Oncol Hematol. 2005) "A major advance in prevention of prostate cancer came in 2003 with the publication of the Prostate Cancer Prevention Trial (PCPT). This overview summarizes the results of that trial, the design of other large-scale trials, and advances in understanding of the molecular mechanisms underlying the effect of other promising agents, including dutasteride, selenium, Vitamin E, Vitamin D, COX-2 inhibitors, lycopene, and green tea."

Selenium/cadmium ratios in human prostates: indicators of prostate cancer risk of smokers and nonsmokers, and relevance to the cancer protective effects of selenium. (Biol Trace Elem Res. 2005) "Selenium (Se) in a large-scale human supplementation trial has been shown to significantly reduce the incidence of prostate cancer in elderly men. Because Se is known to interact with cadmium (Cd), it has been suggested that its cancer protective action could be attributable in part to its interaction with Cd, a toxic and suspected carcinogenic element, which is found in many foods, in drinking water, and in the environment. ? "